You just read:

Multiple Oncotype DX® Presentations at ESMO 2016 Congress Reinforce Its Unique Clinical Utility with Prospective Outcomes Results in Over 63,000 Breast Cancer Patients

News provided by

Genomic Health, Inc.

Oct 10, 2016, 08:00 ET